Morphic Therapeutic Reports Integrin R&D Collaboration With J&J's Janssen; Janssen To Pay Co. Undisclosed Upfront Payment, Will Fund Research Activities; Co. Will Receive From Janssen Multiple Preclinical Development, Clinical, Commercial Milestones
Benzinga Newsdesk